| Typicality: | 0.433 |
| Saliency: | 0.406 |
| in their bodies | 7 | location |
| in the cardiovascular system | 3 | other |
| to enhance neurotransmitter function | 2 | purpose |
| way → reduce → inflammation | 34 |
| way → reduce → the inflammation | 7 |
| way → decrease → inflammation | 6 |
| negative | neutral | positive |
| 0.047 | 0.452 | 0.501 |
| Raw frequency | 47 |
| Normalized frequency | 0.406 |
| Modifier score | 0.800 |
| Perplexity | 91.711 |